VEE Stock Overview Provides cloud-based software for the life sciences industry. More details
Rewards Risk Analysis No risks detected for VEE from our risk checks.
See All Risk Checks Capture your thoughts, links and company narrative
Veeva Systems Inc. Competitors Price History & Performance
Summary of share price highs, lows and changes for Veeva Systems Historical stock prices Current Share Price US$208.70 52 Week High US$242.00 52 Week Low US$157.15 Beta 0.83 1 Month Change -3.65% 3 Month Change 13.55% 1 Year Change 24.12% 3 Year Change -3.91% 5 Year Change 64.65% Change since IPO 521.35%
Recent News & Updates
Veeva Systems Inc. Provides Revenue Guidance for the Fourth Quarter and Full Year Ending January 31, 2025 Dec 06
Veeva Systems Announces Vault CRM Bot and Vault CRM Voice Control, Two New GenAI Capabilities in Vault CRM Nov 26
Veeva Systems Inc. to Report Q3, 2025 Results on Dec 05, 2024 Nov 15
Now 20% undervalued Nov 11
Investor sentiment improves as stock rises 15% Nov 09
New minor risk - Shareholder dilution Oct 17 See more updates
Veeva Systems Inc. Provides Revenue Guidance for the Fourth Quarter and Full Year Ending January 31, 2025 Dec 06
Veeva Systems Announces Vault CRM Bot and Vault CRM Voice Control, Two New GenAI Capabilities in Vault CRM Nov 26
Veeva Systems Inc. to Report Q3, 2025 Results on Dec 05, 2024 Nov 15
Now 20% undervalued Nov 11
Investor sentiment improves as stock rises 15% Nov 09
New minor risk - Shareholder dilution Oct 17
Veeva Systems Inc. Announces Chief Financial Officer Changes Sep 16
Second quarter 2025 earnings released: EPS: US$1.06 (vs US$0.70 in 2Q 2024) Aug 30 Veeva Systems Inc. Updates Earnings Guidance for the Fiscal Year Ending January 31, 2025
Veeva Systems 's Veeva Vault LIMS Gains Momentum as Companies Unify Quality Assurance and Quality Control Aug 22
Veeva Systems Inc. to Report Q2, 2025 Results on Aug 28, 2024 Aug 08
Veeva Systems Inc. Announces CFO Changes Jul 16
First quarter 2025 earnings released: EPS: US$1.00 (vs US$0.82 in 1Q 2024) Jun 04
Investor sentiment deteriorates as stock falls 15% Jun 04
Veeva Systems Inc. Provides Earnings Guidance for the Second Quarter Ending July 31, 2024 and for the Fiscal Year Ending January 31, 2025 May 31
Veeva Systems Inc. Introduces Vault Basics for Biotechs May 18
Veeva Systems Inc. to Report Q1, 2025 Results on May 30, 2024 May 10
Veeva Systems Inc., Annual General Meeting, Jun 12, 2024 Apr 24
Veeva Systems Inc. Provides Earnings Guidance for the First Quarter Ending April 30, 2024 and Fiscal Year Ending January 31, 2025 Mar 01
Full year 2024 earnings released: EPS: US$3.28 (vs US$3.14 in FY 2023) Mar 01
Veeva Systems Inc. Provides Revenue Guidance for the First Quarter Ending April 30, 2024 and Fiscal Year Ending January 31, 2025 Mar 01
Now 20% undervalued Feb 17
Veeva Systems Announces Veeva Vault Submissions Publishing Elearning Feb 12
Veeva Systems Inc. to Report Q4, 2024 Results on Feb 29, 2024 Feb 07
Veeva Systems Announces the Availability of the Full Veeva Compass Suite of Commercial Data Products Jan 30
Third quarter 2024 earnings released: EPS: US$0.84 (vs US$0.70 in 3Q 2023) Dec 07
Veeva Systems Inc. to Report Q3, 2024 Results on Dec 06, 2023 Nov 17
Now 22% undervalued after recent price drop Nov 10
Veeva Systems Inc. provides Earnings Guidance for Its Fiscal Fourth Quarter and Fiscal Year Ending January 31, 2024 and for Its Fiscal Year Ending January 31, 2025 Nov 10
Veeva Systems Inc. Provides Guidance for Its Fiscal Third Quarter Ending October 31, 2023, for Its Fiscal Year Ending January 31, 2024 and for Its Fiscal Year Ending January 31, 2025 Aug 31
Second quarter 2024 earnings released: EPS: US$0.70 (vs US$0.58 in 2Q 2023) Aug 31
Veeva Systems Inc. Appoints Kristine Diamond as Principal Accounting Officer Aug 22
Veeva Systems Inc. to Report Q2, 2024 Results on Aug 30, 2023 Aug 09
Chief Accounting Officer recently sold €59k worth of stock Jun 07
Veeva Business Consulting Expands with New R&D Services Jun 07
First quarter 2024 earnings released: EPS: US$0.82 (vs US$0.65 in 1Q 2023) Jun 01
Veeva Systems Inc. Provides Guidance for the Fiscal Second Quarter Ending July 31, 2023, Updates Guidance for the Fiscal Year Ending January 31, 2024 and Reiterates Guidance for the Fiscal Year Ending January 31, 2025 Jun 01
Veeva Systems Inc., Annual General Meeting, Jun 21, 2023 May 11 Veeva Systems Introduces Link Workflow, A No-Code Platform for Building Custom Workflow Applications
Full year 2023 earnings released: EPS: US$3.14 (vs US$2.79 in FY 2022) Mar 31
Full year 2023 earnings released: EPS: US$3.14 (vs US$2.79 in FY 2022) Mar 03
Veeva Systems Inc. to Report Q4, 2023 Results on Mar 01, 2023 Feb 01
Veeva Systems Inc. Announces Executive Changes Jan 28
Now 21% undervalued after recent price drop Jan 10
Chief Accounting Officer recently sold €1.1m worth of stock Jan 09
Third quarter 2023 earnings released: EPS: US$0.70 (vs US$0.69 in 3Q 2022) Dec 03
Veeva Systems Inc. Provides Earnings Guidance for the Fourth Quarter and Full Year of Fiscal Year Ending January 31, 2023 Dec 02
High number of new directors Nov 16
Veeva Systems Inc. to Report Q3, 2023 Results on Dec 01, 2022 Nov 10
Veeva Systems Inc. Provides Revenue Guidance for the Third Quarter of 2023 Nov 09
Veeva Systems Inc. Introduces Veeva Vault CRM for Medtech Oct 25 Veeva Introduces New ePRO Application for Faster Access to Patient Data
Veeva Systems Inc. Launches New Veeva Link Applications to Give Clinical Teams Real-Time Intelligence to Optimize Site Selection and Trial Design Oct 14
Second quarter 2023 earnings released: EPS: US$0.58 (vs US$0.71 in 2Q 2022) Sep 02
Veeva Systems Inc. Provides Earnings Guidance for the Fiscal Third Quarter Ending October 31, 2022 and Fiscal Year Ending January 31, 2023 Sep 01
Veeva Systems Inc. to Report Q2, 2023 Results on Aug 31, 2022 Aug 04
Court Rejects Medidata Lawsuit Against Veeva Systems Inc. for Lack of Evidence, Blocks Medidata's Moves to Limit Competition and Employee Rights Jul 19
Veeva Systems Inc. Elects Tina Hunt to Serve as Director Jun 14
Chief Accounting Officer recently sold €66k worth of stock Jun 08 Veeva Systems Inc. Announces Clinical Study Training Application
First quarter 2023 earnings released: EPS: US$0.65 (vs US$0.76 in 1Q 2022) Jun 03
Veeva Systems Inc. Provides Earnings Guidance for the Second Quarter Ending July 31, 2022 and Full Year Ending January 31, 2023 Jun 02
Veeva Vault CTMS Enabling Proactive Clinical Trial Management for More Than 150 Companies May 26
Veeva Systems Inc. to Report Q1, 2023 Results on Jun 01, 2022 May 05
High number of new directors Apr 27 Veeva Systems Announces Veeva Data Cloud
Now 20% undervalued after recent price drop Apr 07
Veeva Systems Inc. Appoints Gordon Heneweer as Chief Financial Officer Apr 06
Full year 2022 earnings released: EPS: US$2.79 (vs US$2.52 in FY 2021) Apr 03
Independent Director recently sold €2.1m worth of stock Apr 02
Investor sentiment deteriorated over the past week Mar 09
Full year 2022 earnings: Revenues and EPS in line with analyst expectations Mar 04
Veeva Systems Inc. Provides Earnings Guidance for the First Quarter Ending April 30, 2022 and Fiscal Year Ending January 31, 2023 Mar 04
Cerba Research Unifies Quality Processes with Veeva Vault Quality Suite Mar 03
High number of new directors Feb 02
Veeva Systems Inc. to Report Q4, 2022 Results on Mar 02, 2022 Feb 02
Veeva Systems Inc. (NYSE:VEEV) acquired Veracity Logic, LLC. Dec 14
Third quarter 2022 earnings: EPS in line with analyst expectations despite revenue beat Dec 03
Veeva Systems Inc. Provides Earnings Guidance for the Fiscal Fourth Quarter Ending January 31, 2022, Fiscal Year Ending January 31, 2022 and Fiscal Year Ending January 31, 2023 Dec 02
Veeva Systems Announces New Application to Optimize Quality Control Labs Oct 01
Second quarter 2022 earnings released: EPS US$0.71 (vs US$0.62 in 2Q 2021) Sep 03
Veeva Systems Inc. Provides Revenue Guidance for the Third Quarter and Full Year Ended Ending October 31, 2021 Sep 02
Veeva Systems Inc. (NYSE:VEEV) acquired Learnaboutgmp LLC. Aug 05
Veeva Systems Announces the Availability of 11 New Therapeutic Areas in the Veeva Link Customer Intelligence Platform Jun 10
First quarter 2022 earnings released: EPS US$0.76 (vs US$0.58 in 1Q 2021) May 28
Veeva Provides Earnings Guidance for Fiscal Second Quarter Ending July 31, 2021 and Year Ending January 31, 2022 May 28
Insider recently sold €22k worth of stock Apr 09
Insider recently sold €22k worth of stock Apr 07
Full year 2021 earnings released: EPS US$2.52 (vs US$2.04 in FY 2020) Apr 02
First Patient Completes Digital Consent with Veeva Clinical Network in Phase 2B Study Mar 17
LSK Global PS Adopts Veeva Vault Clinical Applications to Streamline Global Trial Processes Mar 08
Full year 2021 earnings released: EPS US$2.52 (vs US$2.04 in FY 2020) Mar 04
Revenue beats expectations Mar 04
Reckitt Benckiser Standardizes on Veeva Commercial Cloud Applications to Advance Digital Excellence Globally Feb 18 Shareholder Returns VEE DE Healthcare Services DE Market 7D -2.7% -0.02% 0.3% 1Y 24.1% -17.8% 8.4%
See full shareholder returns
Return vs Market: VEE exceeded the German Market which returned 8.4% over the past year.
Price Volatility Is VEE's price volatile compared to industry and market? VEE volatility VEE Average Weekly Movement 5.7% Healthcare Services Industry Average Movement 6.1% Market Average Movement 4.8% 10% most volatile stocks in DE Market 11.8% 10% least volatile stocks in DE Market 2.4%
Stable Share Price: VEE has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: VEE's weekly volatility (6%) has been stable over the past year.
About the Company Veeva Systems Inc. provides cloud-based software for the life sciences industry. It offers Veeva Commercial Cloud, a suite of software and analytics solutions, such as Veeva customer relationship management (CRM) that enable customer-facing employees at pharmaceutical and biotechnology companies; Veeva Vault PromoMats, an end-to-end content and digital asset management solution; Veeva Vault Medical that provides source of medical content across multiple channels and geographies; Veeva Crossix, an analytics platform for pharmaceutical brands; Veeva OpenData, a customer reference data solution; Veeva Link, a data application that allows link to generate real-time intelligence; and Veeva Compass includes de-identified and longitudinal patient data for the United States. The company also provides Veeva Development Cloud, a suite of applications for the clinical, regulatory, quality, and safety functions, including Veeva Vault Clinical, Veeva Vault RIM, Veeva Vault Safety, and Veeva Vault Quality; Veeva QualityOne, a quality and document management, and training solution; Veeva RegulatoryOne, a solution that helps companies to manage regulatory submission content; and Veeva Claims addresses the end-to-end product and marketing claims management process.
Show more Veeva Systems Inc. Fundamentals Summary How do Veeva Systems's earnings and revenue compare to its market cap? VEE fundamental statistics Market cap €33.28b Earnings (TTM ) €649.26m Revenue (TTM ) €2.59b
Earnings & Revenue Key profitability statistics from the latest earnings report (TTM) VEE income statement (TTM ) Revenue US$2.66b Cost of Revenue US$692.57m Gross Profit US$1.96b Other Expenses US$1.30b Earnings US$665.91m
Company Analysis and Financial Data Status Data Last Updated (UTC time) Company Analysis 2025/01/02 22:36 End of Day Share Price 2025/01/02 00:00 Earnings 2024/10/31 Annual Earnings 2024/01/31
Data Sources The data used in our company analysis is from S&P Global Market Intelligence LLC . The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package Data Timeframe Example US Source * Company Financials 10 years Income statement Cash flow statement Balance sheet Analyst Consensus Estimates +3 years Forecast financials Analyst price targets Market Prices 30 years Stock prices Dividends, Splits and Actions Ownership 10 years Top shareholders Insider trading Management 10 years Leadership team Board of directors Key Developments 10 years
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here .
Analysis Model and Snowflake Details of the analysis model used to generate this report is available on our Github page , we also have guides on how to use our reports and tutorials on Youtube .
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources Veeva Systems Inc. is covered by 49 analysts. 31 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst Institution Joseph Vruwink Baird Ishan Majumdar Baptista Research Saket Kalia Barclays
Show 46 more analysts 
